• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自体干细胞移植后入住重症监护病房的比例及其相关因素:印度农村一家三级中心的真实世界经验

Intensive care unit admission rates and factors associated following Autologous stem cell transplantation-real-world experience from a tertiary center in rural India.

机构信息

Department of Clinical Hematology & Medical Oncology, Malabar Cancer Centre, Thalassery, Kannur, Kerala, 670103, India.

出版信息

Support Care Cancer. 2024 Oct 8;32(11):711. doi: 10.1007/s00520-024-08927-z.

DOI:10.1007/s00520-024-08927-z
PMID:39377847
Abstract

PURPOSE

Infectious and other complications can necessitate admission to the intensive care unit (ICU) in autologous stem cell transplantation (ASCT). Data on need for ICU care, impact of various pre- and peri-transplant characteristics on requirement of ICU care and outcomes are scarce from the developing world.

METHODS

A retrospective case record review of ASCT cases was conducted. Pre- and peri-transplant characteristics like infection within 4 weeks of transplant, mucositis, surveillance culture positivity, peri-transplant infections, comorbidity, and time to neutrophil and platelet engraftment were noted.

RESULTS

A total of 109 patients underwent 109 ASCTs. Most common diagnosis was the plasma cell disorder in 75 (69%) patients. Forty-eight (45%) patients had peri-transplant infections. Fifteen (14%) patients had infections with multi-drug resistant (MDR) organisms. Fifteen (14%) patients required ICU care, the most common reason being hypotension in nine patients (8.3%). Four patients (3.7%) required non-invasive ventilation, and one (0.9%) required invasive ventilation. Mortality rate was 1.8% (two patients). Factors associated with the need for ICU care were time to platelet engraftment (median 15 days among those required ICU care versus 13 days who did not, p = 0.04) and presence of peri-transplant infection showed a trend toward ICU care need (19% among those required ICU care versus 7% in those who did not, p = 0.05).

CONCLUSION

Delayed platelet engraftment was associated with the need for ICU care and peri-transplant infections were associated with a trend toward need for ICU care.

摘要

目的

感染和其他并发症可能需要自体干细胞移植(ASCT)患者入住重症监护病房(ICU)。来自发展中国家的数据表明,有关 ICU 护理的需求、各种移植前和移植期间特征对 ICU 护理需求的影响以及结果的数据很少。

方法

对 ASCT 病例进行回顾性病例记录审查。记录移植前和移植期间的特征,如移植前 4 周内感染、黏膜炎、监测培养阳性、移植期间感染、合并症以及中性粒细胞和血小板植入的时间。

结果

共 109 例患者接受了 109 例 ASCT。最常见的诊断是浆细胞疾病,占 75 例(69%)患者。48 例(45%)患者发生移植期间感染。15 例(14%)患者感染了耐多药(MDR)病原体。15 例(14%)患者需要 ICU 护理,最常见的原因是 9 例患者(8.3%)低血压。4 例患者(3.7%)需要无创通气,1 例(0.9%)需要有创通气。死亡率为 1.8%(2 例)。与需要 ICU 护理相关的因素包括血小板植入时间(需要 ICU 护理的患者中位数为 15 天,而不需要 ICU 护理的患者为 13 天,p=0.04)和移植期间感染,需要 ICU 护理的患者比例为 19%,而不需要 ICU 护理的患者比例为 7%(p=0.05)。

结论

血小板植入延迟与需要 ICU 护理相关,移植期间感染与需要 ICU 护理的趋势相关。

相似文献

1
Intensive care unit admission rates and factors associated following Autologous stem cell transplantation-real-world experience from a tertiary center in rural India.自体干细胞移植后入住重症监护病房的比例及其相关因素:印度农村一家三级中心的真实世界经验
Support Care Cancer. 2024 Oct 8;32(11):711. doi: 10.1007/s00520-024-08927-z.
2
Allogeneic stem cell transplant recipients admitted to the intensive care unit during the peri-transplant period have unfavorable outcomes-results of a retrospective analysis from a German university hospital.异基因造血干细胞移植受者在移植期入住重症监护病房的预后较差——德国一所大学附属医院的回顾性分析结果。
Ann Hematol. 2022 Feb;101(2):389-395. doi: 10.1007/s00277-021-04698-3. Epub 2021 Oct 20.
3
Characteristics and outcomes of patients undergoing high-dose chemotherapy and autologous stem cell transplantation admitted to the intensive care unit: a single-center retrospective analysis.接受大剂量化疗和自体干细胞移植并入住重症监护病房的患者的特征和结局:一项单中心回顾性分析。
Ann Hematol. 2023 Jan;102(1):191-197. doi: 10.1007/s00277-022-05028-x. Epub 2022 Nov 17.
4
Infections in hematopoietic stem cell transplant patients admitted to Hematology intensive care unit: a single-center study.造血干细胞移植患者在血液科重症监护病房的感染:一项单中心研究。
Hematology. 2021 Dec;26(1):328-339. doi: 10.1080/16078454.2021.1905355.
5
Pediatric Hematopoietic Stem Cell Transplant and Intensive Care: Have Things Changed?小儿造血干细胞移植与重症监护:情况有变化吗?
Pediatr Crit Care Med. 2016 Mar;17(3):e109-16. doi: 10.1097/PCC.0000000000000607.
6
Outpatient Autologous Stem Cell Transplants for Multiple Myeloma: Analysis of Safety and Outcomes in a Tertiary Care Center.多发性骨髓瘤患者的门诊自体干细胞移植:在三级护理中心的安全性和结果分析。
Clin Lymphoma Myeloma Leuk. 2019 Dec;19(12):784-790. doi: 10.1016/j.clml.2019.09.619. Epub 2019 Oct 9.
7
Allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning regimen: Outcomes of patients admitted to intensive care unit.减低强度预处理方案后异基因造血干细胞移植:入住重症监护病房患者的结局
J Crit Care. 2015 Oct;30(5):1107-13. doi: 10.1016/j.jcrc.2015.06.020. Epub 2015 Jun 24.
8
Optimizing Autologous Stem Cell Transplantation in Multiple Myeloma: The Impact of Intensive Chemomobilization.优化多发性骨髓瘤的自体干细胞移植:强化化疗动员的影响
Transplant Cell Ther. 2024 Aug;30(8):774.e1-774.e12. doi: 10.1016/j.jtct.2024.05.016. Epub 2024 May 18.
9
Impact of pre-transplant individual comorbidities on risk of ICU admission and survival outcomes following allogeneic hematopoietic stem cell transplantation.移植前个体合并症对异基因造血干细胞移植后入住重症监护病房的风险及生存结局的影响。
Bone Marrow Transplant. 2023 Mar;58(3):311-316. doi: 10.1038/s41409-022-01897-y. Epub 2022 Dec 12.
10
Clinical features of life-threatening complications following autologous stem cell transplantation in patients with lymphoma.淋巴瘤患者自体干细胞移植后危及生命并发症的临床特征
Leuk Lymphoma. 2015;56(11):3090-5. doi: 10.3109/10428194.2015.1034700. Epub 2015 May 12.

本文引用的文献

1
Characteristics and outcomes of patients undergoing high-dose chemotherapy and autologous stem cell transplantation admitted to the intensive care unit: a single-center retrospective analysis.接受大剂量化疗和自体干细胞移植并入住重症监护病房的患者的特征和结局:一项单中心回顾性分析。
Ann Hematol. 2023 Jan;102(1):191-197. doi: 10.1007/s00277-022-05028-x. Epub 2022 Nov 17.
2
Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma.三药联合治疗、移植和维持治疗直至骨髓瘤进展。
N Engl J Med. 2022 Jul 14;387(2):132-147. doi: 10.1056/NEJMoa2204925. Epub 2022 Jun 5.
3
Outpatient Autologous Stem Cell Transplants for Multiple Myeloma: Analysis of Safety and Outcomes in a Tertiary Care Center.
多发性骨髓瘤患者的门诊自体干细胞移植:在三级护理中心的安全性和结果分析。
Clin Lymphoma Myeloma Leuk. 2019 Dec;19(12):784-790. doi: 10.1016/j.clml.2019.09.619. Epub 2019 Oct 9.
4
Clinical Outcomes in Multiple Myeloma Post-Autologous Transplantation-A Single Centre Experience.自体移植后多发性骨髓瘤的临床结局——单中心经验
Indian J Hematol Blood Transfus. 2019 Apr;35(2):215-222. doi: 10.1007/s12288-018-0989-y. Epub 2018 Jul 21.
5
Stem Cell Transplantation in Multiple Myeloma: Very Much Alive and Kicking.多发性骨髓瘤中的干细胞移植:依然充满活力且效果显著。
Indian J Hematol Blood Transfus. 2019 Apr;35(2):205-207. doi: 10.1007/s12288-019-01111-y. Epub 2019 Mar 13.
6
Autologous stem cell transplantation in first remission is associated with better progression-free survival in multiple myeloma.自体干细胞移植在第一次缓解期与多发性骨髓瘤患者更好的无进展生存期相关。
Ann Hematol. 2018 Oct;97(10):1869-1877. doi: 10.1007/s00277-018-3370-1. Epub 2018 May 21.
7
Autologous Stem Cell Transplantation for Multiple Myeloma: Single Centre Experience from North India.印度北部单中心多发性骨髓瘤自体干细胞移植经验
Indian J Hematol Blood Transfus. 2018 Apr;34(2):261-267. doi: 10.1007/s12288-017-0876-y. Epub 2017 Sep 19.
8
Safety Outcomes for Autologous Stem Cell Transplant in Multiple Myeloma.自体造血干细胞移植治疗多发性骨髓瘤的安全性结局。
Mayo Clin Proc. 2018 Jan;93(1):56-58. doi: 10.1016/j.mayocp.2017.09.012.
9
Clinical features of life-threatening complications following autologous stem cell transplantation in patients with lymphoma.淋巴瘤患者自体干细胞移植后危及生命并发症的临床特征
Leuk Lymphoma. 2015;56(11):3090-5. doi: 10.3109/10428194.2015.1034700. Epub 2015 May 12.
10
Predictors of mortality in patients undergoing autologous hematopoietic cell transplantation admitted to the intensive care unit.入住重症监护病房的接受自体造血细胞移植患者的死亡率预测因素。
Bone Marrow Transplant. 2009 Mar;43(5):411-5. doi: 10.1038/bmt.2008.336. Epub 2008 Oct 20.